In-licensing
Up-to-date access to technology licensing opportunities worldwide.
- In-licensing
- Browse
Licensing opportunities
NCEs for innovative therapeutic targets in inflammatory/immunologic diseases. More
Our leading apoptosis focused clinical stage drug development company seeks to in-license or acquire early stage clinical projects or technologies at phase I or II in the areas of either oncology or neurology. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2011 - 99 pages - $3,835
Aug 2010 - 80 pages - $1,215
Sep 2010 - 21 pages - $99
Aug 2010 - 138 pages - $1,215
Nov 2010 - 40 pages - $500
Nov 2010 - 40 pages - $500
Apr 2011 - 24 pages - $500
Aug 2011 - 7 pages - $75
Dec 2010 - 27 pages - $500
May 2011 - 32 pages - $500
Your selection
- Industry sector
- Drug discovery del
Browse By
- Industry sector
- Bioinformatics
- Combinatorial biology
- Combinatorial chemistry
- Drug research platforms
- Genomics
- High throughput screening
- Proteomics
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us